Teva DMPA

Alternative Name: TV-46046

Description: A six-month DMPA product.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Short-acting

Regimen:
  • single injection

Active Pharmaceutical Ingredient (API):
  • medroxyprogesterone acetate

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Teva Branded Pharmaceutical Products R&D, Inc.

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase I

Began discovery in: 2012

Active Development: Yes

Status Details:
  • The Phase I work is ongoing.

Additional Information

References:
  • ClinicalTrials.gov Identifier: NCT02817464

Vertical Tabs

Print